Identifying and Targeting Mechanisms of Resistance to BRAF Inhibitors
41,29 €
Moreover, PAK1 inhibition can revert acquired and intrinsic resistance to MAPK pathway inhibitors. In addition, we show that polo-like kinase 3 (PLK3) can modulate MAPK pathway inhibitor efficacy in vitro and in vivo.
Jetzt bei Ebay: